NFE2L2 and amyotrophic lateral sclerosis: These results suggest the fundamental role of astrocytes in determining neuronal antioxidant defenses and highlight the concept that not only the pharmacological target but also the cell type targeted may be relevant when considering an Nrf2-dependent therapeutic approach for ALS.